Results 21 to 30 of about 143,561 (278)

Mutations and amplification of oncogenes in endometrial cancer [PDF]

open access: yes, 1999
Alterations in oncogenes are critical steps in the development of endometrial cancer. To investigate the potential clinical relevance of the amplification of the oncogenes c-erbB2, c-myc, and int-2 and the mutation of K-ras in endometrial cancer, 112 ...
An, Han-Xiang   +5 more
core   +1 more source

Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer [PDF]

open access: yes, 2019
Aims Lymphovascular space invasion (LVSI) in endometrial cancer (EC) is an important prognostic variable impacting on a patient's individual recurrence risk and adjuvant treatment recommendations.
Bartosch, Carla   +11 more
core   +2 more sources

Immunohistochemical Study of ER, PR, Ki67 and p53 in Endometrial Hyperplasias and Endometrial Carcinomas [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Endometrial carcinoma is the second most common gynecologic malignancy in the developing countries. Endometrial Hyperplasia (EH) is a precursor to Endometrioid Adenocarcinoma (EMAC). A 23% of Atypical Hyperplasias (AEH) progress to EMAC.
Nayar Musfera Abdul Masjeed   +4 more
doaj   +1 more source

Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway [PDF]

open access: yes, 2006
We report a multiwavelength (X-ray, ultraviolet/optical/infrared, radio) analysis of the relativistic tidal disruption event candidate Sw J2058+05 from 3 months to 3 yr post-discovery in order to study its properties and compare its behavior with that of
Bower, Geoffrey C.   +15 more
core   +2 more sources

Downregulation of tyrosine threonine kinase inhibits tumor growth via G2/M arrest in human endometrioid endometrial adenocarcinoma

open access: yesTumor Biology, 2017
Endometrial cancer is the most common gynecologic malignancy, about 80% of which is endometrial endometrioid carcinoma. Dysregulation of spindle assembly checkpoint plays a vital role in endometrial endometrioid carcinoma tumorigenesis and progression ...
Jiamiao Zhang   +6 more
doaj   +1 more source

Rapid progression of disease in two cases of undifferentiated endometrial carcinoma

open access: yesGynecologic Oncology Reports, 2019
Undifferentiated endometrial carcinoma, a rare histopathologic diagnosis, has a poor prognosis with high risk of progression during or shortly after completion of adjuvant treatment.
Krista S. Pfaendler, Leslie M. Randall
doaj   +1 more source

The crucial value of serum ferritin in assessing high-risk factors and prognosis for patients with endometrial carcinoma

open access: yesBMC Women's Health, 2023
Background Endometrial carcinoma is a common malignant tumor in female reproductive system. At present, there is no effective and economic prognostic index.
Jiali Liu   +4 more
doaj   +1 more source

LINC00665 enhances tumorigenicity of endometrial carcinoma by interacting with high mobility group AT-hook 1

open access: yesCancer Cell International, 2021
Background Endometrial carcinoma is a frequently diagnosed cancer among females. LncRNAs are reported to be associated with various cancers. Their biological roles in endometrial carcinoma progression is an emerging scientific area. LINC00665 can exert a
Yixuan Cai, Min Hao, Yue Chang, Yun Liu
doaj   +1 more source

Use of contrast-enhanced ultrasound during preoperative evaluation of endometrial carcinoma

open access: yesGynecology and Obstetrics Clinical Medicine, 2021
Objective: To explore the clinical role of contrast-enhanced ultrasound (CEUS) in a preoperative evaluation of early endometrial carcinoma. Methods: This study included 14 patients who underwent preoperative CEUS and contrast-enhanced magnetic resonance ...
Zhao Tian   +5 more
doaj   +1 more source

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for patients with peritoneal metastases from endometrial cancer [PDF]

open access: yes, 2017
Background: More information is needed for selection of patients with peritoneal metastases from endometrial cancer (EC) to undergo cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC). Methods: This study analyzed clinical,
Biacchi, Daniele   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy